Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Cannabix Technologies ( (TSE:BLO) ) is now available.
Cannabix Technologies has completed a commercial delivery of its Marijuana Breath Test system to a major industrial manufacturing client in Virginia via an authorized reseller, underscoring growing adoption of its non-invasive breath-based tools. The client sought a scientifically grounded way to detect recent cannabis use amid rising THC-related safety concerns, labor constraints, and limitations of legacy drug tests that capture historical rather than impairment-relevant use.
The MBT system detects delta-9 THC in breath within about four hours of use at low concentration levels, using proprietary collection hardware and LC-MS lab analysis to align testing with periods of heightened safety risk. This order advances Cannabix’s commercialization strategy in safety-critical sectors, with industrial manufacturing highlighted as a substantial near-term market, and is intended to strengthen its competitive position alongside partners such as Omega Laboratories in setting a new standard for recent-use cannabis testing.
The most recent analyst rating on (TSE:BLO) stock is a Hold with a C$0.67 price target. To see the full list of analyst forecasts on Cannabix Technologies stock, see the TSE:BLO Stock Forecast page.
Spark’s Take on BLO Stock
According to Spark, TipRanks’ AI Analyst, BLO is a Neutral.
The score is held down primarily by weak financial performance—persistent losses, negative margins, and ongoing cash burn that implies financing dependence—despite low leverage. Technicals are a partial positive with the price trading above key moving averages and neutral momentum readings. Valuation remains a secondary drag because negative earnings make P/E less meaningful and there is no dividend support.
To see Spark’s full report on BLO stock, click here.
More about Cannabix Technologies
Cannabix Technologies Inc. is a Canadian developer of marijuana and alcohol breath-testing devices aimed at workplace safety and law enforcement markets. The company focuses on non-invasive, breath-based technologies that detect recent cannabis use, targeting safety-sensitive industries where traditional drug tests are poorly aligned with operational risk and regulatory demands.
Average Trading Volume: 79,430
Technical Sentiment Signal: Buy
Current Market Cap: C$94.39M
Learn more about BLO stock on TipRanks’ Stock Analysis page.